Status:
COMPLETED
HPV Testing In Polish POpulation-based Cervical Cancer Screening Program.
Lead Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborating Sponsors:
Ministry of Health, Poland
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-59 years
Phase:
NA
Brief Summary
The HIPPO PROJECT is a randomized healthcare study nested in the OCCSP in Poland. This project will assess the performance of the new screening test (HR HPV test) before its implementation in Poland.
Detailed Description
The study assumes randomized assumption of 33,000 women aged 30-59 to cytology or HR HPV test in a 1:1 ratio with age stratification (three strata: 30-39, 40-49 and 50-59 years). Patients are recruit...
Eligibility Criteria
Inclusion
- women aged 30-59 with no screening Pap test within the preceding three years in the OCCSP and women with risk factors entitled to annual screening based on information from the SIMP and not tested within preceding 12 months (based on information from the screening database SIMP)
Exclusion
- women with screening Pap test within the preceding three years in the OCCSP
Key Trial Info
Start Date :
October 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
33000 Patients enrolled
Trial Details
Trial ID
NCT04111835
Start Date
October 28 2019
End Date
December 31 2023
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw
Warsaw, Poland